system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, RESULTS. Meshes: Biomarkers, Tumor, Cell Survival, Humans, Inhibitor of Apoptosis Proteins, Kaplan-Meier Estimate, Lymph Nodes, Lymphatic Metastasis, Microtubule-Associated Proteins, Proto-Oncogene Proteins c-bcl-2, RNA, Messenger, STAT3 Transcription Factor, Stomach Neoplasms, Suppressor of Cytokine Signaling 1 Protein, Suppressor of Cytokine Signaling Proteins, Survivin.
user
Does sTAT-3 correlate with lymph node metastasis and cell survival in gastric cancer? Context: To investigate the correlation between gastric cancer growth and signal transducer and activator of transcription-3 (STAT3) expression. We assessed the expressions of STAT3, phosphor-STAT3 (pSTAT3), suppressor of cytokine signaling-1 (SOCS-1), survivin and Bcl-2 in gastric cancer patients after gastrectomy by immunohistochemical method. In addition, in situ hybridization was used to further demonstrate the mRNA expression of STAT3 in gastric cancer. With the univariate analysis, expressions of STAT3, pSTAT3, SOCS-1, survivin and Bcl-2, the size of primary tumor and the lymph node metastasis were found to be associated with the overall survival (OS) of gastric cancer patients. However, only pSTAT3 expression and the lymph node metastasis were identified as the independent factors of OS of gastric cancer with multivariate analysis. STAT3 expression was correlated with the lymph node metastasis. There were positive correlations between expressions of STAT3, survivin, Bcl-2 and pSTAT3 in gastric cancer, whereas there was negative correlation between STAT3 expression and SOCS-1 expression in gastric cancer.
assistant
STAT3 can transform into pSTAT3 to promote the survival and inhibit the apoptosis of gastric cancer cells. SOCS-1 might be the valid molecular antagonist to inhibit the STAT3 expression in gastric cancer. Final Decision: yes